Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.26 is 205% below its 5-year average of -0.41, near the low end of its 5-year range (-1.61–1.28).
0.40% below its 12-month average of -1.26.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.12.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 18 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T12:45:39.131Z. Historical observations retain their original dates. Historical series through 2022-11-07.
EARNINGS PER SHARE (EPS)
-1.26
EARNINGS PER SHARE (EPS) AVG TTM
-1.26
EARNINGS PER SHARE (EPS) AVG 3Y
-1.07
EARNINGS PER SHARE (EPS) AVG 5Y
-0.41
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-0.40%
CURRENT VS 3Y AVG
-17.48%
CURRENT VS 5Y AVG
-204.84%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
BioNexus Gene Lab Corp.
Market Cap
$3.09M
Earnings Per Share (EPS)
-1.26
TTM Avg
-1.26
3Y Avg
-1.07
5Y Avg
-0.41
Market Cap
$2.69M
Earnings Per Share (EPS)
-4.08
TTM Avg
-75.43
3Y Avg
-672.30
5Y Avg
-1025.14
Market Cap
$3.51M
Earnings Per Share (EPS)
-5.19
TTM Avg
-9.51
3Y Avg
-5.92
5Y Avg
-7.35
Market Cap
$2.68M
Earnings Per Share (EPS)
0.16
TTM Avg
0.09
3Y Avg
0.07
5Y Avg
0.07
Market Cap
$2.64M
Earnings Per Share (EPS)
N/A
TTM Avg
-6.90
3Y Avg
-3.65
5Y Avg
-2.32
Market Cap
$3.78M
Earnings Per Share (EPS)
N/A
TTM Avg
-1.00
3Y Avg
-1.16
5Y Avg
-0.42
Market Cap
$4.16M
Earnings Per Share (EPS)
-0.32
TTM Avg
-0.15
3Y Avg
-0.15
5Y Avg
-0.10
Market Cap
$4.18M
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.97M
Earnings Per Share (EPS)
-22.73
TTM Avg
-24.86
3Y Avg
-145.18
5Y Avg
-792.17
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioNexus Gene Lab Corp. (BGLC) | $3.09M | -1.26 | -1.26 | -1.07 | -0.41 |
| DEFSEC Technologies Inc. (DFSC)vs › | $2.69M | -4.08 | -75.43 | -672.30 | -1025.14 |
| Addentax Group Corp. (ATXG)vs › | $3.51M | -5.19 | -9.51 | -5.92 | -7.35 |
| Globavend Holdings Limited (GVH)vs › | $2.68M | 0.16 | 0.09 | 0.07 | 0.07 |
| Top KingWin Ltd. Class A (DPU)vs › | $2.64M | N/A | -6.90 | -3.65 | -2.32 |
| Baiya International Group Inc. (BIYA)vs › | $3.78M | N/A | -1.00 | -1.16 | -0.42 |
| Highway Holdings Limited (HIHO)vs › | $4.16M | -0.32 | -0.15 | -0.15 | -0.10 |
| Liberty Defense Holdings, Ltd. Common Shares (DETX)vs › | $4.18M | N/A | N/A | N/A | N/A |
| Greenwave Technology Solutions, Inc. (GWAV)vs › | $1.97M | -22.73 | -24.86 | -145.18 | -792.17 |
| Galaxy Payroll Group Limited (GLXG)vs › | $1.93M | N/A | 0.09 | 0.66 | 0.63 |
Trailing EPS (TTM)
$-1.26
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.61 |
| 2024-12-31 | -0.90 |
| 2023-12-31 | -1.53 |
| 2022-12-31 | -0.25 |
| 2021-12-31 | 0.53 |
| 2020-12-31 | 1.28 |
| 2019-12-31 | -0.03 |
| 2018-12-31 | 0.00 |
| 2017-12-31 | -0.02 |
| 2016-12-31 | 0.00 |
